JSL Construction & Development Co Ltd
JSL Construction & Development Co., Ltd. operates as a real estate agent and seller in Asia and internationally. The company operates through three segments: Real Estate Selling Agency, Construction, and Development. The company engages in the construction of public housing; development, lease, rent, and sale of residential and commercial buildings; investment, operation, commission, trade, lease, rent, and sale of real estate properties; and trading of building materials, as well as undertakes civil construction engineering projects. It is also involved in the hotel rental and leasing; IT software and third-party payment services; international trade and land development businesses; interior decoration design and contractor services; construction equipment and building material businesses; trading of construction machinery; manufacture of baked food; wholesale and retail of food and beverage; investment in public construction; and property management services. The company was formerly known as Kim Shangchang Development Co., Ltd and changed its name to JSL Construction & Development Co., Ltd. in July 2013. JSL Construction & Development Co., Ltd. was incorporated in 1986 and is headquartered in Taipei City, Taiwan.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 2540-TW would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2000) — listing | $576,673 14.6× | $840,680 14.7× |
| Year 6 (2005) | $576,458 18.3× | $840,381 18.2× |
| Year 11 (2010) | $376,631 15.7× | $552,467 15.6× |
| Year 16 (2015) | $123,642 7.4× | $183,791 7.5× |
| Year 21 (2020) | $31,109 3.3× | $46,513 3.4× |
| Year 26 (2025) | $2,073 1.0× | $3,062 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 2540
For illustration only — not investment advice. Past performance is not indicative of future results.